• Keep an eye on these 15 biotech companies in 2026 
  • Biotech in 2025: A retrospective 
  • Microplastics and pharmaceuticals named a priority threat in drinking water by health, environment officials
  • TerraPower Commits $450M to Build Radioisotope Production Plant
  • China’s X-Humanoid Raises $100M in First Funding Round
  • How Bayer Uses AI to Avoid Sending Customers to its Competition
  • Calcium score predictive of ASCVD risk from elevated Lp(a)
  • HSBC Picks Harvey AI for Lawful Good Plans
  • Public health experts call for stricter glyphosate regulation
  • Sumner Explains Benefits of Microsoft’s Pegasus Program for i-Genie.ai
  • #ISC26: Bayer’s asundexian reduced ischemic strokes by 26% in Phase 3 trial
  • Feb. 20 Policy Watch: Trump orders more glyphosate and phosphorus production
  • Data builds behind Bayer's Kerendia in kidney disease
  • RBC Capital Lowers its Price Target on Bicycle Therapeutics plc (BCYC) to $7 from $11
  • Bayer and Cradle enter collaboration to enhance AI-enabled antibody discovery and optimization
  • Cybersecurity jobs available right now: January 13, 2026
  • The most innovative artificial intelligence companies of 2026
  • Biopharmas Axed 47% More Employees Year Over Year
  • Sanofi linked to takeover bid for Ocular Therapeutix
  • Increasing Rice Yields with Gene-Informed Selective Breeding
  • 2021 Sparked a Banner Year for Biotech IPOs. Where Are They Now?
  • Inside Oxford’s biotech hub: A scientific powerhouse situated in the U.K.’s Golden Triangle
  • The Brave New World of Radiotherapeutics
  • New nanoparticle technology offers hope for hard-to-treat diseases
  • Takeda, Iambic partner in latest pharma AI push
  • NIH stops low-dose Xarelto arm of large stroke study due to safety concerns
  • Anaplan Names Laurent Martini Managing Director for EMEA
  • 2025 Novel Small Molecule FDA Drug Approvals
  • Bayer Shares Briefly Dip After Activist Investor Offloads Millions of Dollars in Company Stock
  • The most innovative companies in agriculture for 2026
  • Voyageur Pharmaceuticals Secures Up to $2.35M Funding from Bayer
  • WellTheory raises $14M Series A led by General Catalyst
  • WellTheory Raises $14M Series A Led by General Catalyst to Fuel Growth and AI Development
Bayer - Latest News and Investment Deals
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Tuesday recap

Top Publishers

  • The Verge AI

    The Verge AI

    21 followers

  • TechCrunch AI

    TechCrunch AI

    19 followers

  • Crunchbase News AI

    Crunchbase News AI

    15 followers

  • TechRadar

    TechRadar

    15 followers

  • Hacker News

    Hacker News

    13 followers

See More →

Top Creators

  • Ryan Allis

    Ryan Allis

    209 followers

  • Elon Musk

    Elon Musk

    80 followers

  • Sam Altman

    Sam Altman

    68 followers

  • Mark Cuban

    Mark Cuban

    57 followers

  • Jack Dorsey

    Jack Dorsey

    40 followers

See More →

Top Companies

  • SaasRise

    SaasRise

    211 followers

  • Anthropic

    Anthropic

    40 followers

  • OpenAI

    OpenAI

    22 followers

  • Hugging Face

    Hugging Face

    15 followers

  • xAI

    xAI

    12 followers

See More →

Top Investors

  • Andreessen Horowitz

    Andreessen Horowitz

    16 followers

  • Y Combinator

    Y Combinator

    15 followers

  • Sequoia Capital

    Sequoia Capital

    12 followers

  • General Catalyst

    General Catalyst

    8 followers

  • A16Z Crypto

    A16Z Crypto

    5 followers

See More →
NewsDealsSocialBlogsVideosPodcasts
HomeBayer
Bayer logo

Bayer

0 followers

BAYN

Performance

About Bayer

Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture, providing innovative solutions to improve people's lives.

Recent News

Keep an Eye on These 15 Biotech Companies in 2026 

Biotech in 2025: A Retrospective 

Microplastics and Pharmaceuticals Named a Priority Threat in Drinking Water by Health, Environment Officials

TerraPower Commits $450M to Build Radioisotope Production Plant

China’s X-Humanoid Raises $100M in First Funding Round

How Bayer Uses AI to Avoid Sending Customers to Its Competition

Calcium Score Predictive of ASCVD Risk From Elevated Lp(a)

HSBC Picks Harvey AI for Lawful Good Plans

Public Health Experts Call for Stricter Glyphosate Regulation

Sumner Explains Benefits of Microsoft’s Pegasus Program for i-Genie.ai

#ISC26: Bayer’s Asundexian Reduced Ischemic Strokes by 26% in Phase 3 Trial

Feb. 20 Policy Watch: Trump Orders More Glyphosate and Phosphorus Production

Data Builds Behind Bayer's Kerendia in Kidney Disease

RBC Capital Lowers Its Price Target on Bicycle Therapeutics Plc (BCYC) to $7 From $11

Bayer and Cradle Enter Collaboration to Enhance AI-Enabled Antibody Discovery and Optimization

Cybersecurity Jobs Available Right Now: January 13, 2026

The Most Innovative Artificial Intelligence Companies of 2026

Biopharmas Axed 47% More Employees Year Over Year

Sanofi Linked to Takeover Bid for Ocular Therapeutix

Increasing Rice Yields with Gene-Informed Selective Breeding

2021 Sparked a Banner Year for Biotech IPOs. Where Are They Now?

Inside Oxford’s Biotech Hub: A Scientific Powerhouse Situated in the U.K.’s Golden Triangle

The Brave New World of Radiotherapeutics

New Nanoparticle Technology Offers Hope for Hard-to-Treat Diseases

Takeda, Iambic Partner in Latest Pharma AI Push

NIH Stops Low-Dose Xarelto Arm of Large Stroke Study Due to Safety Concerns

Anaplan Names Laurent Martini Managing Director for EMEA

2025 Novel Small Molecule FDA Drug Approvals

Bayer Shares Briefly Dip After Activist Investor Offloads Millions of Dollars in Company Stock

The Most Innovative Companies in Agriculture for 2026

Recent Deals

Voyageur Pharmaceuticals Secures Up to $2.35M Funding From Bayer

February 23, 2026

WellTheory Raises $14M Series A Led by General Catalyst

October 15, 2025

WellTheory Raises $14M Series A Led by General Catalyst to Fuel Growth and AI Development

October 15, 2025

Key Facts

HQ Location

Leverkusen, Germany

Founded

1863

Employees

over-10K

Status

Investor

Investor Type

Corporate Investor

Website

https://bayer.com